Pharmaceutical Executive-06-01-2010

Strong, skilled management is on the agenda as never before. Find out who made 2010's roster of high-potential change masters-and how they plan to lead the industry through the turbulent times ahead.

Emerging Pharma Leaders

The public-interest charity takes on pharma-influenced medicing and drug-resistant bacteria.

Improving communication means appealing to physicians' heads as well as their hearts.

Pharma companies can maximize partnership benefits with social media.

Innovation in industry has always required a strong internal champion; the danger is a process led by the risk-adverse and externally-driven stakeholder consensus called "death by faint praise." Is this really what we mean by "bold partnerships?"